Management of Stage 2 Hypertension with Blood Pressure 139/113 mmHg in a Patient Already Taking Lisinopril 10 mg
For a patient with stage 2 hypertension (BP 139/113 mmHg) already taking lisinopril 10 mg, adding a long-acting dihydropyridine calcium channel blocker (CCB) such as amlodipine is the best next step in management.
Rationale for Adding a Calcium Channel Blocker
The current blood pressure reading of 139/113 mmHg indicates inadequate control on lisinopril 10 mg monotherapy. According to the most recent guidelines:
- The 2024 ESC guidelines recommend combination therapy for most patients with confirmed hypertension, with preferred combinations being a RAS blocker (ACE inhibitor or ARB) with either a dihydropyridine CCB or diuretic 1.
- When blood pressure is not controlled on monotherapy, adding a second agent from a different class is recommended rather than simply increasing the dose of the first medication 1.
- The patient is already on an ACE inhibitor (lisinopril), making a dihydropyridine CCB the logical next addition.
Medication Selection Algorithm
- First step (current): ACE inhibitor (lisinopril 10 mg)
- Second step (recommended): Add long-acting dihydropyridine CCB (amlodipine 5 mg)
- Third step (if needed later): Add thiazide/thiazide-like diuretic if BP remains uncontrolled
Benefits of Adding a CCB to Lisinopril
- The combination of an ACE inhibitor and CCB has shown superior efficacy compared to monotherapy with either agent 2, 3.
- In a randomized crossover study, the combination of lisinopril and amlodipine demonstrated significant additional blood pressure-lowering effects compared to either drug alone 3.
- This combination provides complementary mechanisms of action:
- Lisinopril blocks the renin-angiotensin system
- Amlodipine causes peripheral vasodilation through calcium channel blockade
Dosing Considerations
- Start with amlodipine 5 mg once daily
- The combination of low-dose amlodipine (2.5 mg) with lisinopril (5 mg) has been shown to produce significant blood pressure lowering in a higher percentage of patients than individual low-dose therapy 2.
- If blood pressure remains uncontrolled after 2-4 weeks, consider:
- Increasing amlodipine to 10 mg
- Increasing lisinopril to 20-40 mg
- Adding a thiazide diuretic as a third agent
Monitoring Recommendations
- Recheck blood pressure in 2-4 weeks after adding amlodipine
- Monitor for potential side effects:
- Peripheral edema (from CCB)
- Dizziness from enhanced blood pressure lowering
- Electrolytes and renal function
Alternative Approaches
If a CCB is contraindicated or not tolerated, a thiazide or thiazide-like diuretic would be an appropriate alternative second agent 1.
Special Considerations
- The patient's current diastolic BP of 113 mmHg indicates urgent need for better control to reduce cardiovascular risk
- Single-pill combinations of ACE inhibitor and CCB should be considered once doses are stabilized to improve adherence 1, 4
- If BP remains uncontrolled on triple therapy (ACE inhibitor + CCB + diuretic), adding spironolactone should be considered 1
Common Pitfalls to Avoid
- Avoid simply increasing the lisinopril dose without adding a second agent, as combination therapy is more effective than high-dose monotherapy
- Avoid non-dihydropyridine CCBs (verapamil, diltiazem) if the patient has heart failure or conduction abnormalities
- Avoid combining two RAS blockers (such as adding an ARB to the ACE inhibitor), as this is not recommended due to increased adverse effects without additional benefit 1